CLINICAL_TRIALS
trial_result
· 2010-11-05
Clinical Trial Update: Anti-inflammatory Effects of GTS-21 After LPS [NA]
Summary
A completed trial evaluated the anti-inflammatory effects of the alpha7 nicotinic receptor agonist GTS-21 after LPS exposure in endotoxemia and sepsis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radboud University Medical Center | Conditions: Endotoxemia, Sepsis | NA | Status: COMPLETED